High‐grade prostatic intraepithelial neoplasia (HGPIN) appears to represent an ideal target
for chemoprevention of prostate cancer (PCa). HGPIN responds to androgen ablation and …

High-grade prostatic intraepithelial neoplasia (HGPIN) has been identified as a
premalignant change in the prostate that indicates increased risk of the subsequent …

High-grade prostatic intraepithelial neoplasia (HGPIN) is believed to be a precursor for
prostatic adenocarcinoma. The prevalence of prostatic intraepithelial neoplasia (PIN) …

High-grade prostatic intraepithelial neoplasia (HGPIN) is commonly encountered on
prostate needle biopsies and, based on epidemiologic, molecular, and animal models, has …

Purpose High-grade prostatic intraepithelial neoplasia (HGPIN) is a potential precursor of
prostate cancer (PCa), and patients with HGPIN are at high risk for PCa development …

High-grade prostatic intraepithelial neoplasia (HGPIN) is a precursor to invasive prostate
cancer observed as an isolated entity in a growing subset of men undergoing prostate …

Prostatic intraepithelial neoplasia (PIN) is the most established precursor of prostatic
carcinoma. The presence of prominent nucleoli within an existing duct structure is an easy …

There is a tremendous need for exposure biomarkers, which need to function as
intermediate end-points in cancer chemoprevention studies. Likely candidates include …

Subjects diagnosed with high-grade prostatic intraepithelial neoplasia (HGPIN) at biopsy
are at increased risk for developing prostate cancer (CaP). A prospective clinical trial was …

Background: Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti–androgen, flutamide, is used together with conventional …